REVIEWS   

Giornale Italiano di Dermatologia e Venereologia 2006 April;141(2):155-9

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Emerging agents for onychomycosis

Piraccini B. M., Iorizzo M., Rech G., Tosti A.

Department of Dermatology University of Bologna, Bologna, Italy

Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.